JIADING, SHANGHAI, CHINA, January 7, 2026 /EINPresswire.com/ -- As international demand for high-performance separation ...
MoneyShow presents top investment ideas for 2026 from leading advisors. Part 1 includes AbbVie, Alexandria Real Estate ...
Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis ...
The ongoing Special Intensive Revision of electoral rolls in West Bengal has seen the deletion of about 58 lakh names. Our ...
With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...
In-Depth: Meta's suite of three landmark agreements is poised to provide the financial certainty to extend aging plants, ...
DeepSeek has expanded its R1 whitepaper by 60 pages to disclose training secrets, clearing the path for a rumored V4 coding ...
FREDERICK, Md., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...
The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...
“Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior ...
Company achieved significant commercial progress in 2025, generating approximately $378 million in product revenue1 IBSRELA achieved $274 million in revenue in 2025, representing 73% growth vs. 20241 ...
Investing.com -- Genelux Corp (NASDAQ:GNLX) stock fell 10.3% in after-hours trading on Wednesday after the late clinical-stage immuno-oncology company announced a proposed underwritten public offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback